Home
GeniusMed
news Published 2026.08.05

Six PCT international filings completed

International filing is complete for two smart-glasses and autonomous-driving inventions and four Bio AI diagnosis and AI agent inventions.

GeniusMed has completed all six PCT international filings, submitted sequentially between June 2025 and August 2026.

This secures a route into major markets — the United States, Europe, China, Japan and India — for two inventions in smart glasses and autonomous driving and four in Bio AI diagnosis and AI agents.

From 2027 the company will prepare national-phase entry in its priority jurisdictions.

Media Get in Touch

Related

Related

award 2026.08.01

GeniusMed wins the JoongAng Ilbo 2026 Innovative IT Grand Prize

Recognised in the Industrial Convergence & Smart Technology category for Bio AI smart glasses and drowsy-driving prevention.
press 2026.07.29

“Diagnosis, emergency response and driving in a single pair of glasses” — Korean firm partners with a Swiss research institute

GeniusMed, a digital-healthcare specialist, is accelerating development of Bio-AI diagnostic smart glasses with automatic emergency linkage — a platform that brings fundus imaging and vital-sign analysis together in a single pair of glasses, aimed at the global market.
news 2026.07.02

Joint development MoU signed with Switzerland’s CSEM

A two-year agreement to integrate heart rate, HRV, SpO₂, blood pressure and EEG monitoring into smart glasses.